Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Mol Microbiol. 2010 Sep;77(5):1326–1340. doi: 10.1111/j.1365-2958.2010.07293.x

Table 1.

Bacterial strains and plasmids used in this study

Strain or plasmid Relevant features Source or reference
E. coli
DH5⟨ High-efficiency transformation Bethesda Research Laboratories
SM10 Conjugation proficient Simon et al. (1983)
B. pertussis
Tohama I Patient isolate Kasuga et al. (1954)
BP536 StrR, NalR Tohama I Stibitz and Yang (1991)
BP953 BP536, fha-lacZ, ptx-phoA Stibitz (1994)
BP1526 BP953, ΔbvgA1215 This study
Plasm ids
pSS3110 lacZYA promoter assay vector Veal-Carr and Stibitz (2005)
pSS3967 luxCDABE promoter assay vector This study
pQC1025 pSS3967::Pfim2* This study
pSS4159 pSS3967::Pfim3** This study
pQC1030_ pSS3967::PfimX*** This study
pPuvsX-sigma T4 uvsX promoter transcription vector Hinton and Vuthoori (2000)
pPre# PPre# transcription vector This study
pTE103 in vitro transcription vector Elliott and Geiduscheck (1984)
pfha pTE103::Pfha Boucher et al. (1997)
pPfim3-13C pTE103::Pfim3-13C This study
pPfim3-15C pTE103::Pfim3-15C This study
pETsigmaBp B. pertussis Inline graphic subunit expression This study
*

cloned fim2 fragment contains nucleotides 1166483 to 1176644 of the B. pertussis Tohama I genome and extends, relative to the start of transcription, from −130 to +32.

**

cloned fim3 fragment contains nucleotides 1647430 to 1647592 of the B. pertussis Tohama I genome and extends, relative to the start of transcription, from −130 to +33.

***

cloned fimX fragment contains nucleotides 2839614-2839776 of the B. pertussis Tohama I genome and extends, relative to the start of transcription, from −123 to +40.

HHS Vulnerability Disclosure